FOMAT is set to be part of ENDO 2026, taking place June 13 to 16, 2026, in Chicago, Illinois, USA. The event brings together the endocrinology community to share research, clinical insights, and new perspectives in hormone science and patient care.
Steve Schlesinger, Senior Business Development Manager, will represent FOMAT during the event. As our team continues supporting clinical research across therapeutic areas connected to metabolic and endocrine health, ENDO creates a valuable opportunity to connect with organizations interested in future research collaboration.
